YBX2 and cancer testis antigen 45 contribute to stemness, chemoresistance and a high degree of malignancy in human endometrial cancer
Abstract Y-box binding protein 2 (YBX2) has been associated with the properties of both germ cells and cancer cells. We hypothesized that YBX2 might contribute to the characteristics of cancer stem cells (CSCs). In this study, we clarified the function of YBX2 in endometrial cancer stem cells. We es...
Guardado en:
Autores principales: | , , , , , , , , , , , , , , |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/2393a0674b334285888ea55f9ddad4b0 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
id |
oai:doaj.org-article:2393a0674b334285888ea55f9ddad4b0 |
---|---|
record_format |
dspace |
spelling |
oai:doaj.org-article:2393a0674b334285888ea55f9ddad4b02021-12-02T12:11:45ZYBX2 and cancer testis antigen 45 contribute to stemness, chemoresistance and a high degree of malignancy in human endometrial cancer10.1038/s41598-021-83200-52045-2322https://doaj.org/article/2393a0674b334285888ea55f9ddad4b02021-02-01T00:00:00Zhttps://doi.org/10.1038/s41598-021-83200-5https://doaj.org/toc/2045-2322Abstract Y-box binding protein 2 (YBX2) has been associated with the properties of both germ cells and cancer cells. We hypothesized that YBX2 might contribute to the characteristics of cancer stem cells (CSCs). In this study, we clarified the function of YBX2 in endometrial cancer stem cells. We established a human YBX2-expressing Ishikawa (IK) cell line (IK-YBX2 cells). We analyzed gene expression associated with stemness and isolated SP cells from IK-YBX2 cells. The SP population of IK-YBX2 cells, the expression of ALDH1 and serial sphere-forming capacity were associated with levels of YBX2 expression. IK-YBX2 cells were resistant to anti-cancer drugs. In gene expression analysis, a gene for cancer testis antigen, CT45, was generally overexpressed in IK-YBX2 cells. YBX2-mediated CT45 expression was associated with increased levels of self-renewal capacity and paclitaxel resistance. The level of CT45 expression was enhanced in high-grade and/or advanced stages of human endometrial cancer tissues. We conclude that expression of YBX2 is essential for the stem cell-like phenotype. CT45 contributes to stemness associated with YBX2 and might be related to the progression of endometrial cancer.Izumi SuzukiSachiko YoshidaKouichi TabuSoshi KusunokiYumiko MatsumuraHiroto IzumiKazuo AsanomaHiroshi YagiIchiro OnoyamaKenzo SonodaKimitoshi KohnoTetsuya TagaAtsuo ItakuraSatoru TakedaKiyoko KatoNature PortfolioarticleMedicineRScienceQENScientific Reports, Vol 11, Iss 1, Pp 1-14 (2021) |
institution |
DOAJ |
collection |
DOAJ |
language |
EN |
topic |
Medicine R Science Q |
spellingShingle |
Medicine R Science Q Izumi Suzuki Sachiko Yoshida Kouichi Tabu Soshi Kusunoki Yumiko Matsumura Hiroto Izumi Kazuo Asanoma Hiroshi Yagi Ichiro Onoyama Kenzo Sonoda Kimitoshi Kohno Tetsuya Taga Atsuo Itakura Satoru Takeda Kiyoko Kato YBX2 and cancer testis antigen 45 contribute to stemness, chemoresistance and a high degree of malignancy in human endometrial cancer |
description |
Abstract Y-box binding protein 2 (YBX2) has been associated with the properties of both germ cells and cancer cells. We hypothesized that YBX2 might contribute to the characteristics of cancer stem cells (CSCs). In this study, we clarified the function of YBX2 in endometrial cancer stem cells. We established a human YBX2-expressing Ishikawa (IK) cell line (IK-YBX2 cells). We analyzed gene expression associated with stemness and isolated SP cells from IK-YBX2 cells. The SP population of IK-YBX2 cells, the expression of ALDH1 and serial sphere-forming capacity were associated with levels of YBX2 expression. IK-YBX2 cells were resistant to anti-cancer drugs. In gene expression analysis, a gene for cancer testis antigen, CT45, was generally overexpressed in IK-YBX2 cells. YBX2-mediated CT45 expression was associated with increased levels of self-renewal capacity and paclitaxel resistance. The level of CT45 expression was enhanced in high-grade and/or advanced stages of human endometrial cancer tissues. We conclude that expression of YBX2 is essential for the stem cell-like phenotype. CT45 contributes to stemness associated with YBX2 and might be related to the progression of endometrial cancer. |
format |
article |
author |
Izumi Suzuki Sachiko Yoshida Kouichi Tabu Soshi Kusunoki Yumiko Matsumura Hiroto Izumi Kazuo Asanoma Hiroshi Yagi Ichiro Onoyama Kenzo Sonoda Kimitoshi Kohno Tetsuya Taga Atsuo Itakura Satoru Takeda Kiyoko Kato |
author_facet |
Izumi Suzuki Sachiko Yoshida Kouichi Tabu Soshi Kusunoki Yumiko Matsumura Hiroto Izumi Kazuo Asanoma Hiroshi Yagi Ichiro Onoyama Kenzo Sonoda Kimitoshi Kohno Tetsuya Taga Atsuo Itakura Satoru Takeda Kiyoko Kato |
author_sort |
Izumi Suzuki |
title |
YBX2 and cancer testis antigen 45 contribute to stemness, chemoresistance and a high degree of malignancy in human endometrial cancer |
title_short |
YBX2 and cancer testis antigen 45 contribute to stemness, chemoresistance and a high degree of malignancy in human endometrial cancer |
title_full |
YBX2 and cancer testis antigen 45 contribute to stemness, chemoresistance and a high degree of malignancy in human endometrial cancer |
title_fullStr |
YBX2 and cancer testis antigen 45 contribute to stemness, chemoresistance and a high degree of malignancy in human endometrial cancer |
title_full_unstemmed |
YBX2 and cancer testis antigen 45 contribute to stemness, chemoresistance and a high degree of malignancy in human endometrial cancer |
title_sort |
ybx2 and cancer testis antigen 45 contribute to stemness, chemoresistance and a high degree of malignancy in human endometrial cancer |
publisher |
Nature Portfolio |
publishDate |
2021 |
url |
https://doaj.org/article/2393a0674b334285888ea55f9ddad4b0 |
work_keys_str_mv |
AT izumisuzuki ybx2andcancertestisantigen45contributetostemnesschemoresistanceandahighdegreeofmalignancyinhumanendometrialcancer AT sachikoyoshida ybx2andcancertestisantigen45contributetostemnesschemoresistanceandahighdegreeofmalignancyinhumanendometrialcancer AT kouichitabu ybx2andcancertestisantigen45contributetostemnesschemoresistanceandahighdegreeofmalignancyinhumanendometrialcancer AT soshikusunoki ybx2andcancertestisantigen45contributetostemnesschemoresistanceandahighdegreeofmalignancyinhumanendometrialcancer AT yumikomatsumura ybx2andcancertestisantigen45contributetostemnesschemoresistanceandahighdegreeofmalignancyinhumanendometrialcancer AT hirotoizumi ybx2andcancertestisantigen45contributetostemnesschemoresistanceandahighdegreeofmalignancyinhumanendometrialcancer AT kazuoasanoma ybx2andcancertestisantigen45contributetostemnesschemoresistanceandahighdegreeofmalignancyinhumanendometrialcancer AT hiroshiyagi ybx2andcancertestisantigen45contributetostemnesschemoresistanceandahighdegreeofmalignancyinhumanendometrialcancer AT ichiroonoyama ybx2andcancertestisantigen45contributetostemnesschemoresistanceandahighdegreeofmalignancyinhumanendometrialcancer AT kenzosonoda ybx2andcancertestisantigen45contributetostemnesschemoresistanceandahighdegreeofmalignancyinhumanendometrialcancer AT kimitoshikohno ybx2andcancertestisantigen45contributetostemnesschemoresistanceandahighdegreeofmalignancyinhumanendometrialcancer AT tetsuyataga ybx2andcancertestisantigen45contributetostemnesschemoresistanceandahighdegreeofmalignancyinhumanendometrialcancer AT atsuoitakura ybx2andcancertestisantigen45contributetostemnesschemoresistanceandahighdegreeofmalignancyinhumanendometrialcancer AT satorutakeda ybx2andcancertestisantigen45contributetostemnesschemoresistanceandahighdegreeofmalignancyinhumanendometrialcancer AT kiyokokato ybx2andcancertestisantigen45contributetostemnesschemoresistanceandahighdegreeofmalignancyinhumanendometrialcancer |
_version_ |
1718394560699170816 |